Antidiuretic Drugs Market Research Report Information: By Type (Vasopressin, Desmopressin, Oxytocin, others), By Indication (Diabetes Insipidus, Hemophilia, Hypertension, others), By End Users (Hospitals, Clinics, Pharmaceutical Companies, others) - Global Forecast till 2032

Global Antidiuretic Drugs Market Overview

Key Players in the Global Antidiuretic Drugs Market      

Some of the key players in this market are: 

• Par Sterile Products, LLC (U.S.)


• ADH Health (U.S.)


• Azevan Pharmaceuticals, Inc. (U.S.)


• Teva Pharmaceutical Industries Ltd. (Israel)


• Otsuka Holdings Co. Ltd (Japan)


• Taj Pharmaceuticals Limited (India)


• ALLERGAN (U.S.)

Global Antidiuretic Drugs Market Segmentation         

The global antidiuretic drugs market is segmented on the basis of types, which includes vasopressin, desmopressin, oxytocin, and others. Other types of antidiuretic drugs are argipressin, lypressin, ornipressin and terlipressin. On the basis of indication, the market is segmented into diabetes insipidus, hemophilia, hypertension, and others. Diabetes insipidus is further sub-segmented into central diabetes insipidus, nephrogenic diabetes insipidus, dipsogenic diabetes insipidus and gestational diabetes insipidus. Other indications are polyuria, polydipsia and enuresis. On the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies, and others.

Regional Analysis of the Global Antidiuretic Drugs Market         

The American region accounted for the largest share of the global market due to increasing prevalence of diabetes insipidus, and rising demand for new drugs for the treatment of diabetes insipidus. The rate of diabetes insipidus is much higher in America than the rest of the world. According to the Diabetes Insipidus Organization, in the U.S., 1 in 6,666 American may develop diabetes insipidus. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population was suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.

Europe is the second largest market that holds a noticeable share of the global antidiuretic drugs market. Diabetes insipidus is a common postoperative complication among children who have undergone transsphenoidal craniotomy.

In Asia Pacific, rising awareness about diabetes insipidus, huge geriatric population suffering from diabetes insipidus and increase in the risk of developing diabetes insipidus after surgery is driving the market growth. Furthermore, rising awareness about the use of antidiuretic drugs for the treatment of diabetes insipidus also propels the market growth. Middle East and Africa show steady growth in the antidiuretic drugs market. 

The report on the global antidiuretic drugs market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions. 

Intended Audience

• Pharmaceutical companies


• Medical Research Laboratories


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors